Circius Pharma ApS: Financial statements 2023
CVR: 42447641
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Circius Pharma ApS (CVR 42447641) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,770,374 and a net result of DKK -2,242,451 compared with DKK -15,906 the year before. That is an increase of 0.2% compared with the year before. Equity in the 2023 report amounted to DKK 3,437,320. The solvency ratio was 51.6%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,770,374
- Profit/Loss
- DKK -2,242,451
- Equity
- DKK 3,437,320
- Total Assets
- DKK 6,659,011
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 2.8 mio. | -2.2 mio. | 3.4 mio. | 2 |
| 2022 | - | 2.8 mio. | -16 t. | 5.7 mio. | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of October 16, 2023, Johan Lindberg is registered as director of Circius Pharma ApS.
As of October 16, 2023, Jörgen Mikael Carlson has stepped down as director of Circius Pharma ApS.
Circius Pharma ApS has published its annual report for 2022. Gross profit came to DKK 2,765,694, and the net result was DKK -15,906.
About Circius Pharma ApS
Circius Pharma ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2021. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jan Erik Gustav Smith, Jan Gustav Smith and Johan Lindberg. The company is owned by Circius Pharma AB. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 2,858,282 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 3,437,320.